naturalX Health Ventures

Key facts

Stages

Seed, Series A, Series B

Sectors

Healthtech

Ticket

€3M–€10M

Eligible countries

Not stated

Provider based in

Germany

Timing

Rolling applications

Focus

consumer health; preventive health; sleep; gut health; longevity

How to apply

Apply route unknown

Source

https://longevity.technology/news/new-e100-million-fund-aims-to-drive-consumer-health-innovation-in-europe

Recent deals

No deals in our data for the last 24 months.

Evidence

Short excerpts from the sources, in their original language, that back the facts above.

• KindnaturalX Health Ventures has launched a €100 million fund focused on advancing consumer health in the regionhttps://longevity.technology/news/new-e100-million-fund-aims-to-drive-consumer-health-innovation-in-europe
• Sectorsfirst specialized investment fund in Europe to focus exclusively on consumer health.https://longevity.technology/news/new-e100-million-fund-aims-to-drive-consumer-health-innovation-in-europe
• StagesThe fund’s primary focus is on Series-A investments, although it will also consider late Seed and Series-B roundshttps://longevity.technology/news/new-e100-million-fund-aims-to-drive-consumer-health-innovation-in-europe
• Ticketoffering initial investments ranging from €3-5 million and up to €10 million per company.https://longevity.technology/news/new-e100-million-fund-aims-to-drive-consumer-health-innovation-in-europe
• Ticketoffering initial investments ranging from €3-5 million and up to €10 million per company.https://longevity.technology/news/new-e100-million-fund-aims-to-drive-consumer-health-innovation-in-europe

Status history

• 7 Nov 2026: Rolling → Uncertain (freshness: investor activity)
• 6 Nov 2026: Rolling (first extraction)